CE vs G · rev $10.28B vs P/E 16, rev $5.08B
Celanese Corporation (CE) versus Genpact Limited (G) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Genpact Limited (G) is a information technology services company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported G revenue for 2025-12-31 was $5.08B. Net income was $552.5M. Revenue was up 6.6% from 2024-12-31 to 2025-12-31. G currently screens at market cap $8.07B and trailing P/E 15.5.
CE currently screens at market cap $5.92B. G currently screens at market cap $8.07B and trailing P/E 15.5.
Not investment advice. Open the CE and G stock pages for the full models.
Not investment advice.